OrthoPediatrics Innovates Pediatric Orthopedics with New System
OrthoPediatrics Launches Revolutionary Spinal Growth System
OrthoPediatrics Corp. (NASDAQ: KIDS), renowned for its dedication to enhancing pediatric orthopedic care, has recently marked a significant milestone by successfully completing the first surgical procedures in the United States using its innovative VerteGlide Spinal Growth Guidance System. This state-of-the-art technology aims to address the urgent and complex needs associated with Early Onset Scoliosis (EOS).
Surgeons Praise the Efficacy of VerteGlide
Dr. Richard McCarthy, a leading pediatric orthopedic spine surgeon involved in the initial procedures, expressed his enthusiasm, noting, "The first procedures with VerteGlide were notably successful. Given the limited options available for these children, this groundbreaking system addresses a substantial clinical need. The future looks promising as many more children will benefit from this innovation." His sentiments highlight the essential role that advanced medical technologies play in pediatric care.
The Technology Behind VerteGlide
VerteGlide stands at the forefront of scoliosis treatment options, utilizing cutting-edge implant and instrument technology to cater specifically to early onset scoliosis patients. This advanced system not only simplifies one of the most challenging spinal deformities to treat but also provides surgeons with access to exceptional tools that can directly address the most affected areas of the spinal structure.
Commitment to Pediatric Orthopedics
Greg Odle, President of the Scoliosis division at OrthoPediatrics, emphasized the collaborative effort that led to the development of VerteGlide. By working with a team of elite surgeons who possess extensive practical knowledge in pediatric orthopedic treatments, they have crafted a system that stands among the most advanced globally. The drive for innovation in this field ensures that patients benefit from the latest technological advancements.
Future Engagements and Presentations
As part of its commitment to continuous improvement and knowledge-sharing within the medical community, OrthoPediatrics will showcase VerteGlide at both the upcoming Scoliosis Research Society Annual Meeting and the International Congress on Early Onset Scoliosis. These forums will not only illuminate the capabilities of VerteGlide but also enhance collaboration within the orthopedic community toward common goals.
Company Overview and Market Reach
Founded in 2006, OrthoPediatrics has firmly established itself as a leader in pediatric orthopedics. The company prides itself on its comprehensive line of over 80 products, which address crucial areas including trauma management, deformity correction, and sports medicine. With its focused sales strategy, OrthoPediatrics caters to both the U.S. market and over 70 countries worldwide, dedicated to improving the lives of children affected by orthopedic conditions.
For further details regarding OrthoPediatrics and its portfolio, please contact their investor relations through Philip Trip Taylor at Gilmartin Group via email or phone.
Frequently Asked Questions
What is the VerteGlide Spinal Growth Guidance System?
The VerteGlide system is an advanced surgical technology developed by OrthoPediatrics intended for the treatment of Early Onset Scoliosis by providing precise spinal growth guidance.
Who were the first surgeons to use the VerteGlide?
Dr. Richard McCarthy and Dr. Kent Walker were among the first to perform surgeries employing the VerteGlide system.
What is Early Onset Scoliosis (EOS)?
EOS is a type of scoliosis that develops in children under the age of 10, resulting in an abnormal curvature of the spine that can lead to serious health issues if not treated effectively.
How many products does OrthoPediatrics offer?
OrthoPediatrics offers more than 80 products that serve various areas within pediatric orthopedics, including scoliosis, trauma, and sports medicine.
Where can I learn more about OrthoPediatrics and its products?
You can visit their official website at www.orthopediatrics.com or contact their investor relations through the provided email.
About The Author
Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
